Liver Enzyme Alteration Prof. Dr. Orhan Tarçın Gastroenteroloji Bölümü.

Slides:



Advertisements
Similar presentations
Group D Florendo-Gaspar.  Tests based on detoxification and excretory functions  Tests that measure biosynthetic function  Coagulation factors  Other.
Advertisements

Serina Farzin-Nasab, MD Emory University Family Medicine Residency Program.
Steve Bradley Chief Medical Resident, HMC Inpatient Services
Predictors of elevated transaminase levels in patients with central obesity V. Papastergiou, G. Ntetskas, L. Skorda, F. Lambrianou, K. Roufas, E. Asonitis,
Liver Function Tests (LFTs)
1 CLINICAL CHEMISTRY-2 (MLT 302) LIVER FUNCTION AND THE BILIARY TRACT LECTURE FOUR Dr. Essam H. Aljiffri.
1 Serum Enzymes in Disease Dr. Essam H. Aljiffri.
CLINICAL CHEMISTRY-2 (MLT 302) LIVER FUNCTION AND THE BILIARY TRACT LECTURE FIVE Dr. Essam H. Aljiffri.
AST, ALT & ALP Lab. 5.
Enzymes in Body Fluids Lecture outline
Clinical Model for NASH and Advanced Fibrosis in Adult Patients With Diabetes and NAFLD: Guidelines for Referral in NAFLD Featured Article: Jessica Bazick,
Dr Yasir M Khayyat,MBcHB,FRCPC,FACP 1 Khayyat Y. LFT WhyHowWhenWHO 600 ريال 2 Khayyat Y.
Liver disease Prepared by: Siti Norhaiza Bt Hadzir.
Abnormal LFTs Liver disease is often asymptomatic Deranged LFTs may be the only sign of a serious underlying liver disease Or they may be nothing wrong!
Sinusoids of liver are delicate structure and their walls are composed of endothelium. Sinusoids blockage can cause dilatation of these structures, liver.
Hepatitis C for the General Practitioner Morris Sherman MB BCh PhD FRCP(C) University of Toronto January 2013.
By Dr. Abdelaty Shawky Assistant Professor of Pathology
Alcohol and Abnormal Blood Tests Dr Steve Brinksman Dr Martyn Hull.
Hepatic Function Tests CMS approved Hepatic Function Panel Total protein Albumin AST ALT ALP Total Bilirubin Direct bilirubin.
MLAB 2401: Clinical Chemistry Keri Brophy-Martinez Alterations in Liver Function.
This lecture was conducted during the Nephrology Unit Grand Ground by Medical Student rotated under Nephrology Division under the supervision and administration.
Alanine Transaminase.
Liver function tests Lecture 3.
By: H.Baniamerian Kermanshah university of medical science.
Aminotransferases. AMINOTRANSFERASES Definition – Interconversion of amino acids to 2-oxo-acids – Amino group donor – Amino group acceptor Aminotransferases.
Significance of Liver Function Tests
Cholestatic liver diseases:
Primary Sclerosing Cholangitis
Liver Function Tests. Tests Based on Detoxification and Excretory Functions.
Liver Function Tests (LFTs)
Biochemical markers in disease diagnosis
Serum biochemical parameters (ALT) (AST) assay Biochemistry Clinical practice CLS 432 Dr. Samah Kotb Lecturer of Biochemistry 2015.
Evaluating the Patient With Abnormal Liver Tests-2 פרופ ' צבי אקרמן מבית חולים הדסה הר הצופים.
The Use of Mortality Data to Improve Risk Assessment CTHOLUA Seminar February, 2011 Robert Stout, Ph.D., President and Director Clinical Reference Laboratory.
Blood Studies Liver function test (LFT) Group of biochemical tests Group of biochemical tests Uses of liver function test (LFTs) Differential diagnosis.
Cirrhosis Dr. Meg-angela Christi M. Amores. Cirrhosis a histopathologically defined condition – pathologic features consist of the development of fibrosis.
Module 4: Testing and monitoring. Module 5: Testing and monitoring Module goal To introduce participants to best practice regarding the different tests,
Cellular Biochemistry and Metabolism (CLS 333 ) Dr. Samah Kotb Nasr Eldeen Serum biochemical parameters (ALT) (AST) assay.
Clinical diagnostic biochemistry - 10 Dr. Maha Al-Sedik 2015 CLS 334.
Enzymes AST, ALT & ALP Lab. 6.
Biochemical markers for diagnosis and follow up of disease
Hepatitis. Hepatitis * Definition: Hepatitis is necro-inflammatory liver disease characterized by the presence of inflammatory cells in in the portal.
Liver function Tests What are liver tests? Liver tests (LTs) are blood tests used to assess the general state of the liver or biliary system. Few of these.
Lab # 2 Liver Function Tests (LFTs) ALT&AST T.A. Bahiya M. Osrah.
Khadija Balubaid KAU-Faculty of Science- Biochemistry department Clinical biochemistry lab (BIOC 416) 2013 Liver Function profile (LFT) Enzymes.
Steve Bradley Chief Medical Resident, HMC Inpatient Services.
CHRONIC HEPATITIS B SEROLOGY
Course of Advanced Diagnostics Integrated laboratory evaluation of liver Prof. Giuseppe Castaldo, a.y
INTERPRETATION OF LABORATORY & DIAGNOSTIC TESTS GI SYSTEM Nora A.Kalagi, MSc. 326 PHCL April 2016.
1-urin and stool findings: hemolyticobstructivehepatocellular Urine bilinogenincreasedabsentMay increase or decrease Faeces stercobilinincreaseddecreasedDecreased.
Abnormal liver enzyme levels liver enzyme levels symptoms or signs suggestive of liver disease isolated, unexpected finding challenge even for the experienced.
Lab (2): Liver Function profile (LFT)
Laboratory tests in digestive systema Klinika Gastroenterologii Dr n. med. Małgorzata Pujanek.
Alcoholic Liver Disease Prof.Dr. Khalid A. Al-Khazraji MBCHB, CABM, FRCP, FACP Baghdad medical college
LIVER FUNCTION TESTS
Liver Function Tests (LFTs)
Diagnostic Pathway for Chronic Liver Disease
Patient no 7 Primary Biliary Cirrhosis Lipoprotein X
Liver Function Tests (LFTs)
Lab (2): Liver Function profile (LFT)
INVESTIGATION OF HEPATOBILIARY DISEASE
Liver Function Tests.
biochemical markers for diagnosis and follow up of diseases
Underwriting Screening Liver Test Abnormalities:
Chronic viral hepatitis type B with “ground glass” cells
Determination of the enzyme ALT (SGPT) & AST activity in serum by enzymatic method using Biophotometer.
Hepatic Function Tests
Gastroenterology & Nutrition Block Biochemistry Department
Response to abnormal liver blood tests.
Fig. 4: Schematic, initial diagnostic algorithm for a patient presenting with mild aminotransferase abnormality. Fig. 4: Schematic, initial diagnostic.
Presentation transcript:

Liver Enzyme Alteration Prof. Dr. Orhan Tarçın Gastroenteroloji Bölümü

Biochemical markers of liver damage Isolated alterations in healthy patients Guidelines ? Classify: hepatocellular vs. cholestatic Initial investigation

Liver enzyme levels Aim of this presentation: Defines the laboratory diagnosis for abnormal liver enzyme. Providing how to in the interprate the liver enzyme alterations.

***Edoardo G. Giannini, MD

Normal Ranges: How to apply reference ranges? Performance characteristics (reproducibility, bias, total error). Definition: a value exceeding the upper reference limit is abnormal. Low levels has no significance – except: serum albumin. Use your own laboratory ranges… Remember there are patients with subclinical liver disease included. 2.5% of “normal” patients have “abnormal” - AST or ALT Some patients with chronic hepatitis C- 16%, non-alcoholic fatty liver-13% have normal laboratory measurement with abnormal histological findings. Age and sex limits Activity- exercise: ↑ALT & ↑AST Hospital patients- diet? And ↓exercise restriction- ↓

Fig. 1: Schematic representation of an approach to liver enzyme alteration. Specific modalities of enzyme alteration (how) and their relation with peculiar characteristics of the patient and locality (where and when) should be thoroughly assessed before the definitive diagnostic work-up is begun.

Where, When and How Always ask questions…Traveling…Ethnicity Where? Who is your patient? – Example: Bayamón, P.R. – 50%- ↑ALT (genetics?) – Wales- 60% - ↑ AST (due to ischemic or toxic liver disease). – Far East- orofecal transmittable hepatitis viruses (60%) are the major causes of sporadic acute and fulminant hepatitis.⁵ – Primary Biliary Cirrhosis 2% in Australia;.424 per 100,000 in Asia. – Homozygosity for the C282Y mutation in the HFE gene can be found in about 5/1000 people of Northern European descent but.0001/100 people of African American ethnicity.

When? Timing in relation to age of the patient – Example: Wilson’s disease – early in life Comorbid conditions should be explore Ingestion of medications. – Date it started with relation to alterations. – Almost any medication can liver enzymes. – Herbal remedies are overlooked. – Over the counter meds..

How? First piece of evidence: Pattern. – Disease: Common causes have typical patterns… – Careful examination- Predominant pattern- (hepatocellular vs. cholestatic) Magnitude of alteration ( 10 times); mild, moderate or marked. Rate of change (increase or decrease over time) The nature of the course of alteration (mild fluctuations vs. progressive)

Serum aminotransferace levels in various liver disease

Hepatocellular predominant and cholestatic predominant Fundamental to narrowing down the differential diagnosis. Certain liver diseases may display a mixed biochemical picture- – ↑AST and ↑ALT with mild abnormalities of alkaline phosphatase (ALP) and gamma- glutamyl transpeptidase (GGT) levels-

Hepatocellular predominant AST and ALT increased: – are enzymes that catalyze the transfer of α-amino groups from aspartate and alanine to the α-keto group of ketoglutaric acid to generate oxalacetic and pyruvic acids respectively, which are important contributors to the citric acid cycle. Both enzymes require pyridoxal-5’-phosphate (vitamin B6) in order to carry out this reaction, although the effect of pyridoxal-5’-phosphate deficiency is greater on ALT activity than on that of AST. This has clinical relevance in patients with alcoholic liver disease, in whom pyridoxal-5’-phosphate deficiency may decrease ALT serum activity and contribute to the increase in the AST/ALT ratio that is observed in these patients.

Hepatocellular predominance Both aminotransferases are highly concentrated in the liver. AST is also diffusely represented in the heart, skeletal muscle, kidneys, brain and red blood cells, and ALT has low concentrations in skeletal muscle and kidney. An increase in ALT serum levels is, therefore, more specific for liver damage

Marked and moderate aminotransferace increase > 10 times the upper reference limit: acute hepatic injury. – Data suggest that the most sensitive and specific aminotransferase threshold is within the moderate range (5-10 at 200 IU/L for AST and 300 IU/L for ALT).

Schematic representation of the rate of change of aminotransferace and bilirubin levels in a patient with acute ischemic hepatitis (green and yellow) and acute viral hepatitis.(blue and orange) figure 3

A minimal or mild increase in aminotransferase level is the most common biochemical alteration encountered in everyday clinical practice. Mild increase in aminotransferase levels

Nonalcoholic fatty liver disease is the most common cause of mild alteration of liver enzyme levels in the western world, and, according to the National Health and Nutritional Survey, point-prevalence is about 23% among American adults. The biochemical picture includes mildly raised aminotransferase levels, and GGT levels can be elevated up to 3 times the upper reference value in nearly half of patients in the absence of ethanol consumption. As with chronic viral hepatitis, an AST/ALT ratio greater than 1, which is observed in 61% of patients with advanced fibrosis and 24% of patients with no or initial fibrosis, is highly suggestive of advanced liver disease

Mild increase in aminotransferase Suspicion of nonalcoholic fatty liver disease is increased by the presence of conditions linked to the metabolic syndrome and insulin resistance (increased body mass index, diabetes, hyperlipemia, hypertension), although the disease may occur in patients without these associated factors.

All patients presenting with mild increases in aminotransferase levels should be questioned about risk factors for hepatitis B or C infection (intravenous drug use, exposure to nonsterile needles or sexual exposure to an infected person). However, since these 2 diseases have a high prevalence worldwide and infected people may lack or underreport specific risk factors for infection, testing for HCV antibodies and hepatitis B surface antigens is advisable for all patients presenting with a mild increase in aminotransferase levels. If the patient tests positive for HCV antibodies, then qualitative HCV RNA testing should follow.

Cholestatic predominance Presentation of liver injury with a prevalent cholestatic pattern is less frequently encountered in clinical practice than the pattern of hepatocellular damage. ALP and bilirubin levels are routinely assessed, and the level of GGT is often measured as an additional aid toward diagnosis in particular situations because of its high sensitivity but low specificity. (Dosage of AlP isoenzymes is a more complicated technique and expensive, so GGT is preferred)

Albumin and prothrombin time assessment: Are we really testing liver function? Determining serum albumin levels and assessing prothrombin time are often considered “tests of liver function.” …because hepatic synthesis of albumin tends to decrease in end-stage liver disease Increase in prothrombin time depends on the decreased synthesis of liver-derived coagulation factors., In fact, Albumin is produced by hepatocytes, and prothrombin time depends on the activity of clotting factors I, II, V, VII and X, which are produced in the liver. Neither test is specific for liver disease, since albumin serum levels may decrease in patients with nephrotic syndrome, malabsorption or protein-losing enteropathy, or malnutrition, andprothrombin time may be prolonged by warfarin treatment, deficiency in vitamin K (which is needed to activate clotting factors II, VII and X) and consumptive coagulopathy.

Conclusions Alterations in liver enzyme levels are one of the most common problems encountered in everyday clinical practice. Finding the way through the multiple diagnostic pathways can challenge even the experienced clinician. Knowledge of the pathophysiology of liver enzymes is an essential guide to understanding their alteration. The pattern of enzyme abnormality, interpreted in the context of the patient’s characteristics, can aid in directing the subsequent diagnostic work-up. Awareness of the prevalence of determined liver disease in specific populations and of possible hepatic involvement during systemic illnesses or drug therapies may help the clinician identify the cause of alterations efficiently.